Confronting a biological armageddon: experts tackle prospect of bioterrorism

Article Abstract:

Many federal agencies and local governments are developing plans to deal with the use of biological weapons by terrorists. The March, 1995, attack on the Tokyo subway system by terrorists wielding the nerve gas sarin illustrated the serious consequences of bioterrorism. Iraq has a substantial research program in biological weapons and some of Russia's biological weapons technology could fall into the wrong hands. Biological weapons could become the weapon of choice because they are not detected by X-rays and metal detectors and the perpetrator would be long gone before symptoms developed.

Usage, Equipment and supplies, Biological weapons, Terrorism

---

IOM Report a Blueprint for Elimination of TB

Article Abstract:

The Institute of Medicine has released a report detailing the efforts needed to eliminate tuberculosis from the US. After effective TB drugs were introduced in 1953, many doctors believed the disease would be eliminated. Federal funding for tuberculosis control ended in 1972 and as a result, the infection staged a comeback. Most cases of TB in the US occur in immigrants from countries where TB is prevalent. All immigrants should be screened before they enter the US. Other high-risk groups include prisoners, homeless people, intravenous drug users, and HIV patients.

Prevention, Tuberculosis

---

Studies reveal early impact of HIV infection, effects of treatment

Article Abstract:

Important information about the treatment of HIV infection was discussed at the Fifth Conference on Retroviruses and Opportunistic Infections in Feb, 1998. Early drug treatment with protease inhibitors appears to preserve helper T cells which activate killer T cells that can keep the virus in check. It is not known if these helper T cells will persist if treatment is stopped. One side effect of protease inhibitors appears to be deposits of fat in various parts of the body, along with elevated blood lipid levels.

Complications and side effects, HIV infection, Drug therapy, HIV infections, Protease inhibitors

Similar abstracts:

• Abstracts: Creating calendar and table templates in Microsoft PowerPoint. Creating flowcharts in Microsoft PowerPoint
• Abstracts: Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. Injectable Paromomycin for Visceral Leishmaniasis in India
• Abstracts: Building a better mousetrap: toward an understanding of osteoporosis. The body's skin frontier and the challenges of wound healing: keloids
• Abstracts: Medical malpractice - the Canadian experience. Disparities in the use of total joint arthroplasty. Differences between men and women in the rate of use of hip and knee arthroplasty
• Abstracts: Treatment for Alzheimer's disease? Neurologic disorder in a 65-year-old man after treatment of colon cancer. A 74-year-old man with memory loss, language impairment, and personality changes

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.